{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:12:23Z","timestamp":1781244743747,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","award":["S2022\/BMD-7274"],"award-info":[{"award-number":["S2022\/BMD-7274"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2021-123507OB-I00"],"award-info":[{"award-number":["PID2021-123507OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C18915\/A29362"],"award-info":[{"award-number":["C18915\/A29362"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neo.2025.101240","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:17:03Z","timestamp":1760804223000},"page":"101240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Adverse prognosis of GM-CSF expression in human cutaneous melanoma"],"prefix":"10.1016","volume":"70","author":[{"given":"Elena","family":"Garc\u00eda-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8236-7591","authenticated-orcid":false,"given":"Alicia","family":"Nieto-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Barrio-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-5419","authenticated-orcid":false,"given":"Baltasar","family":"L\u00f3pez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9451-4392","authenticated-orcid":false,"given":"Jos\u00e9 Antonio","family":"Avil\u00e9s-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Parra-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6282-3932","authenticated-orcid":false,"given":"Alba","family":"Guti\u00e9rrez-Seijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"S\u00e1nchez-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3081-7332","authenticated-orcid":false,"given":"Rafael","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101240_bib0001","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.neo.2025.101240_bib0002","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","article-title":"Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease","volume":"54","author":"Mulder","year":"2021","journal-title":"Immunity."},{"key":"10.1016\/j.neo.2025.101240_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1587545","article-title":"Translating genetics into tissue: inflammatory cytokine-producing TAMs and PD-L1 tumor expression as poor prognosis factors in cutaneous melanoma","volume":"16","author":"Barrio-Alonso","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2025.101240_bib0004","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/febs.14343","article-title":"The roles of CSFs on the functional polarization of tumor-associated macrophages","volume":"285","author":"Jeannin","year":"2018","journal-title":"FEBS. J."},{"key":"10.1016\/j.neo.2025.101240_bib0005","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.celrep.2019.09.035","article-title":"Signal integration and transcriptional regulation of the inflammatory response mediated by the GM-\/M-CSF signaling axis in Human monocytes","volume":"29","author":"Rodriguez","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2025.101240_bib0006","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/jir.2014.0149","article-title":"Dual role of GM-CSF as a pro-inflammatory and a regulatory cytokine: implications for immune therapy","volume":"35","author":"Bhattacharya","year":"2015","journal-title":"J. Interferon. Cytokine Res."},{"key":"10.1016\/j.neo.2025.101240_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/08977194.2011.649919","article-title":"The GM-CSF receptor family: mechanism of activation and implications for disease","volume":"30","author":"Hercus","year":"2012","journal-title":"Growth Factors. Taylor Fr.;"},{"key":"10.1016\/j.neo.2025.101240_bib0008","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1182\/blood.2024024330","article-title":"GM-CSF receptor expression determines opposing innate memory phenotypes at different stages of myelopoiesis","volume":"143","author":"Guerrero","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.neo.2025.101240_bib0009","first-page":"589","article-title":"Oral squamous cell carcinoma cell-derived GM-CSF regulates PD-L1 expression in tumor-associated macrophages through the JAK2\/STAT3 signaling pathway","volume":"13","author":"Wang","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.neo.2025.101240_bib0010","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145296","article-title":"Breast cancer\u2013derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment","volume":"131","author":"Su","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2025.101240_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.901277","article-title":"GM-CSF: a double-edged sword in cancer immunotherapy","volume":"13","author":"Kumar","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2025.101240_bib0012","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.4049\/jimmunol.1103426","article-title":"Defining GM-CSF\u2013 and macrophage-CSF\u2013Dependent macrophage responses by In vitro models","volume":"188","author":"Lacey","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2025.101240_bib0013","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1158\/0008-5472.CAN-03-3301","article-title":"Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells","volume":"64","author":"Obermueller","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101240_bib0014","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1038\/emm.2016.64","article-title":"Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types","volume":"48","author":"Hong","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neo.2025.101240_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317692232","article-title":"Granulocyte-macrophage colony-stimulating factor increases tumor growth and angiogenesis directly by promoting endothelial cell function and indirectly by enhancing the mobilization and recruitment of proangiogenic granulocytes","volume":"39","author":"Zheng","year":"2017","journal-title":"Tumour. Biol."},{"key":"10.1016\/j.neo.2025.101240_bib0016","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.4049\/jimmunol.1103817","article-title":"Stabilization of HIF-2\u03b1 induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model","volume":"189","author":"Roda","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2025.101240_bib0017","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/cells9071683","article-title":"Inter-tumor heterogeneity\u2014Melanomas respond differently to GM-CSF-mediated activation","volume":"9","author":"Moshe","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neo.2025.101240_bib0018","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/jcm14041200","article-title":"Advancements in Melanoma treatment: a review of PD-1 inhibitors, T-VEC, mRNA vaccines, and tumor-infiltrating lymphocyte therapy in an evolving landscape of immunotherapy","volume":"14","author":"Mehta","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neo.2025.101240_bib0019","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.3390\/cancers13163943","article-title":"CCL20\/TNF\/VEGFA cytokine secretory phenotype of tumor-associated macrophages is a negative prognostic factor in cutaneous melanoma","volume":"13","author":"Guti\u00e9rrez-Seijo","year":"2021","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2025.101240_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/path.6252","article-title":"Chemokine profiling of melanoma-macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma","volume":"262","author":"Barrio-Alonso","year":"2024","journal-title":"J. Pathol."},{"key":"10.1016\/j.neo.2025.101240_bib0021","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jid.2021.07.179","article-title":"Activin A sustains the metastatic phenotype of tumor-associated macrophages and is a prognostic marker in Human cutaneous melanoma","volume":"142","author":"Guti\u00e9rrez-Seijo","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neo.2025.101240_bib0022","first-page":"D1161","article-title":"The Cellosaurus: a cell-line knowledge resource","volume":"46","author":"Bairoch","year":"2018","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.neo.2025.101240_bib0023","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.neo.2025.101240_bib0024","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1091\/mbc.6.5.497","article-title":"A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF","volume":"6","author":"Nishijima","year":"1995","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neo.2025.101240_bib0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","article-title":"A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis","volume":"25","author":"Su","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2025.101240_bib0026","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/gutjnl-2021-324109","article-title":"GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity","volume":"71","author":"Ruffolo","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.neo.2025.101240_bib0027","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/0008-5472.CAN-12-0806","article-title":"Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors","volume":"73","author":"Urdinguio","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101240_bib0028","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-13-2774","article-title":"GM-CSF production by tumor cells is associated with improved survival in colorectal cancer","volume":"20","author":"Nebiker","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101240_bib0029","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1200\/JCO.2005.07.168","article-title":"Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases","volume":"23","author":"Dai","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2025.101240_bib0030","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/cancers11101448","article-title":"STAT3 and STAT5 targeting for simultaneous management of melanoma and autoimmune diseases","volume":"11","author":"Logotheti","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101240_bib0031","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1136\/gutjnl-2016-313075","article-title":"Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway","volume":"66","author":"Wang","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.neo.2025.101240_bib0032","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/cgt.2016.19","article-title":"Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases","volume":"23","author":"Thorn","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.neo.2025.101240_bib0033","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/cam4.239","article-title":"A role for G-CSF and GM-CSF in nonmyeloid cancers","volume":"3","author":"Aliper","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.neo.2025.101240_bib0034","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1158\/0008-5472.CAN-21-0259","article-title":"Autocrine GMCSF signaling contributes to growth of HER2+ breast leptomeningeal carcinomatosis","volume":"81","author":"Ansari","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101240_bib0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cyto.2011.11.016","article-title":"Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas","volume":"57","author":"Revoltella","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.neo.2025.101240_bib0036","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cam4.20","article-title":"GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression","volume":"2","author":"Gutschalk","year":"2013","journal-title":"Cancer Med."},{"key":"10.1016\/j.neo.2025.101240_bib0037","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1158\/0008-5472.CAN-06-0158","article-title":"Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo","volume":"66","author":"Gutschalk","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101240_bib0038","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-16-2706","article-title":"Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages","volume":"77","author":"Huang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101240_bib0039","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1476-4598-9-273","article-title":"Macrophages may promote cancer growth via a GM-CSF\/HB-EGF paracrine loop that is enhanced by CXCL12","volume":"9","author":"Rigo","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2025.101240_bib0040","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.3390\/cancers16162910","article-title":"Paracrine activation of STAT3 drives GM-CSF expression in breast carcinoma cells, generating a symbiotic signaling network with breast carcinoma-associated fibroblasts","volume":"16","author":"Osuala","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101240_bib0041","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.2300326","article-title":"Dose-specific intratumoral GM-CSF modulates breast tumor oxygenation and antitumor immunity","volume":"211","author":"Mihalik","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2025.101240_bib0042","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1158\/1078-0432.CCR-09-1540","article-title":"Effect of granulocyte\/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine","volume":"15","author":"Faries","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101240_bib0043","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1001\/jama.2014.13943","article-title":"Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial","volume":"312","author":"Hodi","year":"2014","journal-title":"JAMa"},{"key":"10.1016\/j.neo.2025.101240_bib0044","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2015.62.0500","volume":"33","author":"Lawson","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2025.101240_bib0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40425-019-0623-z","article-title":"Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma","volume":"7","author":"Andtbacka","year":"2019","journal-title":"J. ImmunOther Cancer"},{"issue":"9","key":"10.1016\/j.neo.2025.101240_bib0046","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00262-016-1860-3","article-title":"Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma","volume":"65","author":"Hoeller","year":"2016","journal-title":"Cancer Immunol. Immunther."},{"key":"10.1016\/j.neo.2025.101240_bib0047","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic virotherapy promotes intratumoral T cell infiltration and improves Anti-PD-1 immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neo.2025.101240_bib0048","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009541","article-title":"Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy","volume":"12","author":"Kang","year":"2024","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.neo.2025.101240_bib0049","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2025.101240_bib0050","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/2159-8290.CD-15-0947","article-title":"GM-CSF mediates mesenchymal\u2013Epithelial cross-talk in pancreatic cancer","volume":"6","author":"Waghray","year":"2016","journal-title":"Cancer Discov."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:27:44Z","timestamp":1762381664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625001204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"alternative-id":["S1476558625001204"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101240","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse prognosis of GM-CSF expression in human cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101240"}}